Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Merck
McKinsey
Johnson and Johnson
Medtronic

Last Updated: August 15, 2022

Investigational Drug Information for Poloxamer 407


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Poloxamer 407?

Poloxamer 407 is an investigational drug.

There have been 4 clinical trials for Poloxamer 407. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Mucositis, Periodontitis, and Stomatitis. The leading clinical trial sponsors are University of California, San Francisco, National Cancer Institute (NCI), and Medical University of South Carolina.

Recent Clinical Trials for Poloxamer 407
TitleSponsorPhase
Nitazoxanide as a New Local Adjunctive to Nonsurgical Treatment of Moderate PeriodontitisMaha TalaabPhase 2
Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant MucositisAmerican College of Prosthodontists Education FoundationPhase 2
Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant MucositisGreater New York Academy of ProsthodonticsPhase 2

See all Poloxamer 407 clinical trials

Clinical Trial Summary for Poloxamer 407

Top disease conditions for Poloxamer 407
Top clinical trial sponsors for Poloxamer 407

See all Poloxamer 407 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Merck
McKinsey
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.